These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12965938)

  • 21. Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS.
    Boman J; Roblin PM; Sundström P; Sandström M; Hammerschlag MR
    Neurology; 2000 Jan; 54(1):265. PubMed ID: 10636169
    [No Abstract]   [Full Text] [Related]  

  • 22. Presence of Chlamydia pneumoniae DNA in the cerebral spinal fluid is a common phenomenon in a variety of neurological diseases and not restricted to multiple sclerosis.
    Gieffers J; Pohl D; Treib J; Dittmann R; Stephan C; Klotz K; Hanefeld F; Solbach W; Haass A; Maass M
    Ann Neurol; 2001 May; 49(5):585-9. PubMed ID: 11357948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diagnostic tests: Chlamydia trachomatis, Chlamydophila pneumoniae].
    Kishimoto T; Ando S; Ogawa M
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():220-6. PubMed ID: 16111232
    [No Abstract]   [Full Text] [Related]  

  • 24. Real time PCR for detection of Chlamydophila pneumoniae in peripheral blood mononuclear cells of patients with multiple sclerosis.
    Sessa R; Schiavoni G; Borriello G; Zagaglia C; Marinelli F; del Piano M; Pozzilli C
    J Neurol; 2007 Sep; 254(9):1293-5. PubMed ID: 17460814
    [No Abstract]   [Full Text] [Related]  

  • 25. Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS.
    Sriram S
    Neurology; 2000 Nov; 55(9):1423-4. PubMed ID: 11087807
    [No Abstract]   [Full Text] [Related]  

  • 26. Under the microscope: focus on Chlamydia pneumoniae infection and multiple sclerosis.
    Fainardi E; Castellazzi M; Seraceni S; Granieri E; Contini C
    Curr Neurovasc Res; 2008 Feb; 5(1):60-70. PubMed ID: 18289023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of chlamydial bodies and antigens in the central nervous system of patients with multiple sclerosis.
    Sriram S; Ljunggren-Rose A; Yao SY; Whetsell WO
    J Infect Dis; 2005 Oct; 192(7):1219-28. PubMed ID: 16136465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chlamydia pneumoniae infection associated with enhanced MRI spinal lesions in multiple sclerosis.
    Hao Q; Miyashita N; Matsui M; Wang HY; Matsushima T; Saida T
    Mult Scler; 2002 Oct; 8(5):436-40. PubMed ID: 12356213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular identification and antibody testing of Chlamydophila pneumoniae in a subgroup of patients with HIV-associated dementia complex. Preliminary results.
    Contini C; Fainardi E; Seraceni S; Granieri E; Castellazzi M; Cultrera R
    J Neuroimmunol; 2003 Mar; 136(1-2):172-7. PubMed ID: 12620657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is Chlamydia pneumoniae present in brain lesions of patients with multiple sclerosis?
    Hammerschlag MR; Ke Z; Lu F; Roblin P; Boman J; Kalman B
    J Clin Microbiol; 2000 Nov; 38(11):4274-6. PubMed ID: 11060110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity marker.
    Krametter D; Niederwieser G; Berghold A; Birnbaum G; Strasser-Fuchs S; Hartung HP; Archelos JJ
    Mult Scler; 2001 Feb; 7(1):13-8. PubMed ID: 11321187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chlamydia pneumoniae-specific serum immune complexes in patients with multiple sclerosis.
    Parratt J; Tavendale R; O'Riordan J; Parratt D; Swingler R
    Mult Scler; 2008 Apr; 14(3):292-9. PubMed ID: 18208884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chlamydia pneumoniae and multiple sclerosis: the latest etiologic candidate.
    Bashir K; Kaslow RA
    Epidemiology; 2003 Mar; 14(2):133-4. PubMed ID: 12606874
    [No Abstract]   [Full Text] [Related]  

  • 34. [Chlamydia pneumoniae infection and multiple sclerosis].
    Wender M
    Neurol Neurochir Pol; 2002; 36(3):489-92. PubMed ID: 12185805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of serum oligoclonal antibody responses to Chlamydophila pneumoniae in multiple sclerosis.
    Chapman MD; Hartley JC; Furrows SJ; Ridgeway GL; Thompson EJ; Church AJ; Candler PM; Giovannoni G
    Eur Neurol; 2005; 53(2):81-3. PubMed ID: 15812167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does Chlamydia pneumoniae play a role in the pathogenesis of multiple sclerosis?
    Stratton CW; Mitchell WM; Sriram S
    J Med Microbiol; 2000 Jan; 49(1):1-3. PubMed ID: 10628821
    [No Abstract]   [Full Text] [Related]  

  • 37. Lack of detectable Chlamydia pneumoniae in brain lesions of patients with multiple sclerosis.
    Ke Z; Lu F; Roblin P; Boman J; Hammerschlag MR; Kalman B
    Ann Neurol; 2000 Sep; 48(3):400. PubMed ID: 10976653
    [No Abstract]   [Full Text] [Related]  

  • 38. Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis.
    Bagos PG; Nikolopoulos G; Ioannidis A
    Mult Scler; 2006 Aug; 12(4):397-411. PubMed ID: 16900753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of Chlamydia infection of the central nervous system in multiple sclerosis.
    Pucci E; Taus C; Cartechini E; Morelli M; Giuliani G; Clementi M; Menzo S
    Ann Neurol; 2000 Sep; 48(3):399-400. PubMed ID: 10976652
    [No Abstract]   [Full Text] [Related]  

  • 40. [Multiple sclerosis. Chlamydia hypothesis in debate].
    Derfuss T; Hohlfeld R; Meinl E
    Nervenarzt; 2001 Oct; 72(10):820-3. PubMed ID: 11688186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.